Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)
- 21:00 - 23:59
- 8/06/2022
- Location: On-Demand
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Yi-Long Wu, Chunxue Bai, Caicun Zhou, Karen Kelly
-
+
WS08.11 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
22:50 - 23:00 | Presenter: Yun Fan | Author(s): Alexander Drilon, Chao-Hua Chiu, Daniel W. Bowles, Herbert H.F. Loong, Salvatore Siena, Koichi Goto, Maciej Krzakowski, Myung-Ju Ahn, Haruyasu Murakami, Rafal Dziadziuszko, Harald Zeuner, Bethany Pitcher, Diarra Cheick, Matthew G. Krebs
- Abstract
This abstract is currently under embargo and will be released during the conference.
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-016 - Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs
Presenter: Benjamin Besse | Author(s): Nicolas Girard, Reyes Bernabé Caro, Koichi Goto, Natasha Leighl, Yuichiro Ohe, Joshua Sabari, Se-Hoon Lee, Xiwu Lin, Marcy Schaeffer, Sandhya Nair, Tracy Li, Lilla Di Scala, Ravi Potluri, Parthiv Mahadevia, Meena Thayu, Tae Min Kim- Abstract
Loading... -
+
EP08.02-019 - Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Alexander Spira | Author(s): David Spigel, Ross Camidge, Adrianus J de Langen, Tae Min Kim, Koichi Goto, Yasir Elamin, Elaine Shum, Karen Reckamp, Julia Rotow, Sarah B. Goldberg, Shirish Gadgeel, Ticiana Leal, Faris Albayya, Sarah Fitzpatrick, Melinda Louie-Gao, Jagan Parepally, Alena Zalutskaya, Helena A. Yu- Abstract
Loading... -
+
EP08.02-045 - Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Elaine Shum | Author(s): Yasir Elamin, Zofia Piotrowska, David Spigel, Karen Reckamp, Julia Rotow, Daniel SW Tan, Sun Min Lim, Tae Min Kim, Chia-Chi Lin, Terufumi Kato, Jagan Parepally, Faris Albayya, Melinda Louie-Gao, Tessa Weining, Alena Zalutskaya, Koichi Goto- Abstract
Loading... -
+
EP08.02-113 - Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
Presenter: Masanobu Okahisa | Author(s): Hibiki Udagawa, Shingo Matsumoto, Terufumi Kato, Satoshi Oizumi, Naoki Furuya, Daisuke Hayakawa, Ryo Toyozawa, Akihiro Nishiyama, Kadoaki Ohashi, Shingo Miyamoto, Kazumi Nishino, Hajime Oi, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, Eri Sugiyama, Kaname Nosaki, Yoshitaka Zenke, Kiyotaka Yoh, Koichi Goto- Abstract
Loading... -
+
EP08.02-173 - Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings
Presenter: Joshua Sabari | Author(s): Steve Pisano, Katrin Gemmler, Judith Mueller, Reyes Bernabé-Caro, Nicolas Girard, Koichi Goto, Natasha Leighl, Yuichiro Ohe, Tae Min Kim, Se-Hoon Lee, Levon Demirdjian, Raymond Harvey, Sarah Rudolph, Parthiv Mahadevia, Joshua M Bauml, Benjamin Besse- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Lorenza Landi, Jii Bum (Joy) Lee
-
+
MA13.04 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
12:07 - 12:12 | Presenter: Yun Fan | Author(s): Alexander Drilon, Chao-Hua Chiu, Daniel W. Bowles, Herbert Loong, Salvatore Siena, Koichi Goto, Maciej Krzakowski, Myung-Ju Ahn, Haruyasu Murakami, Rafal Dziadziuszko, Harald Zeuner, Bethany Pitcher, Diarra Cheick, Matthew Krebs
- Abstract
Loading...
